Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Should Patents On REMS Distribution Restrictions Be Banned?

Apr 17 2014

• By Sue Sutter

Related Content

Generic Companies Gain Little From FDA Decision On Access To REMS Drugs

Aug 13 2013

REMS Hurdles To Generic Entry: From Brand Access To Patent Claims

Oct 22 2012

PDUFA Negotiations: REMS Mud-Slinging, Supply Chain Compromising, GAIN Diminishing?

Jun 18 2012

Shared REMS Systems Show Challenges Of Standardization – Could PDUFA V Help?

Jul 22 2013

REMS Modification Guidance Coming As FDA Rejects Petition For Shared REMS Rules

Oct 22 2013

Brand, Generic Disputes Over Access Move Beyond REMS Restrictions

May 13 2013

Related Companies

Viatris Inc.

Bristol Myers Squibb Company

Actelion Pharmaceuticals Ltd.

Dr. Reddy's Laboratories Ltd.

Prometheus Laboratories Inc.

Additional Topics

United States Regulation BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window